Abstract
Atherosclerotic cardiovascular disease is a major cause of mortality and morbidity in Western countries, leading to 759,000 deaths annually in the United States1. The pathogenesis of atherosclerosis is complex, multifactorial, and involves both environmental and genetic risk factors. Steinberg2 schematically illustrated the proposed interplay of blood factors with arterial wall responses (Figure 1). Since many of these factors are discussed elsewhere,3 this review will focus on the central role of lipoproteins in atherosclerosis. Specifically, this review will examine the evidence linking dietary cholesterol and fat intake to serum lipoproteins and coronary heart disease (CHD), the strength of the relationships between atherosclerosis and serum lipoproteins, clinical trials focusing on lowering serum lipoproteins to reduce risk for CHD, animal and human regression studies, the effects of dietary fiber on serum lipoproteins and CHD, and practical implications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
U.S. Department of Health and Human Services, “The Surgeon General’s Report on Nutrition and Health,” U.S. Government Printing Office, Washington (1988).
D. Steinberg, Lipoproteins and atherosclerosis: a look back and a look ahead, Arteriosclerosis 3:283 (1983).
J.W. Anderson, D.A. Deakins, T.L. Floore, B.M. Smith, and S.E. Whitis, Dietary fiber and coronary heart disease, CRC Reviews, in press.
N. N. Anitschkow, A history of experimentation on arterial atherosclerosis in animals, in: “Cowdry’s Arteriosclerosis: A Survey of the Problem,” C.C. Thomas, Springfield (1967).
M.G. Bond, B.C. Bullock, D.A. Bellinger, and T.E. Hamm, Myocardial infarction in a large colony on nonhuman primates with coronary artery atherosclerosis, Am. J. Pathol. 101:675 (1980).
R.W. Wissler, Principles of the pathogenesis of atherosclerosis, in: “Heart Disease: A Textbook of Cardiovascular Medicine,” E. Braunwald, ed., W.B. Saunders Company, Philadelphia (1984).
A. Keys, “Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease,” Harvard University Press, Cambridge (1980).
A.C. Arntzenius, D. Kromhout, J.D. Barth, J.H.C. Reiber, A.V.G. Bruschke, B. Buis, C.M. van Gent, N.Kempen-Voogd, S. Strikwerda, and E.A. van der Velde, Diet, lipoproteins, and the progression of coronary atherosclerosis New Engl. J. Med. 312:805 (1985).
M.L. Armstrong, E.D. Warner, and W. E. Connor, Regression of coronary atheromatosis in Rhesus monkeys, Circulation Res. 27:59 (1970).
T.B. Clarkson, M.G. Bond, B. C. Bullock, K.J. McLaughlin, and J.K. Sawyer, A study of atherosclerosis regression in Macaca mulatta, Exp. Mol. Pathol. 41:96 (1984).
C.J. Glueck, D.J. Gordon, J.J. Nelson, C.E. Davis, and H. A. Tyroler, Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial, Am. J. Clin. Nutr. 44:489 (1986).
F.M. Sacks, J. Salazar, L. Miller, J.M. Foster, M. Sutherland, K.W. Samonds, J.J. Albers, and E.H. Kass, Ingestion of egg raises plasma low density lipoproteins in free-living subjects, Lancet 1:647 (1984).
J. Stamler and R. Shekelle, Dietary cholesterol and human coronary heart disease: the epidemiologic evidence, Arch. Pathol. Lab. Med. 112:1032 (1988).
W.E. Connor, and S.L. Connor, The key role of nutritional factors in the prevention of coronary heart disease, Prev. Med. 1:49 (1972).
A. Keys, Diet, in: “Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease,” Harvard University Press, Cambridge (1980).
D.M. Hegsted, and L.M. Ausman, Diet, alcohol and coronary heart disease in men, J. Nutr. 118:1184 (1988).
Inter-Society Commission for Heart Disease Resources, Optimal resources for primary prevention of atherosclerotic disease, Circulation 70:153A (1984).
J. Stamler, D. Wentworth, and J.D. Neaton, Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?, JAMA 256:2823 (1986).
Consensus Conference, Lowering blood cholesterol to prevent heart disease, JAMA 253:2080 (1985).
S.M. Grundy, Cholesterol and coronary heart disease: a new era, JAMA 256:2849 (1986).
W.B. Kannel, W.P. Castelli and T. Gordon, Cholesterol in the prediction of atherosclerotic disease, Ann. Intern. Med. 90:85 (1979).
The Pooling Project Research Group, Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project, J. Chron. Dis. 31:201 (1978).
C. Aravanis, The classic risk factors for coronary heart disease: experience in Europe, Prev. Med. 12:16 (1983).
N. Rifai, Lipoproteins and apolipoproteins: composition, metabolism and association with coronary heart disease. Arch. Pathol. Lab. Med. 110:694 (1986).
W. P. Castelli, J.T. Doyle, T. Gordon, C.G. Hames, M.C. Hjortland, S.B. Hulley, A. Kagan, and W.J. Zukel, HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping Study, Circulation 55:767 (1977).
The Lipid Research Clinics Program, The Lipid Research Clinics Coronary Primary Prevention Trial Results: reduction in incidence of coronary heart disease, JAMA 251:351 (1984).
D.J. Gordon, and B.M. Rifkind, High-density lipoprotein — the clinical implications of recent studies, New Engl. J. Med. 321:1311 (1989).
W.B. Kannel, High-density lipoproteins: epidemiologic profile and risks of coronary artery disease, Am. J. Cardiol. 52:9B (1983).
H. Aberg, H. Lithell, I. Selinus, and H. Hedstrand, Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris, Atherosclerosis 54:89 (1985).
T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber, High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study, Am. J. Med. 62:707 (1977).
K.M. West, M.M.S. Ahuja, P.H. Bennett, A. Czyzyk, O. Mateo De Acosta, J.H. Fuller, B. Grab, V. Grabauskas, R.J. Jarrett, K. Kosaka, H. Keen, A.S. Krolewski, E. Miki, V. Schliack, A. Teuscher, P.J. Watkins, and J.A. Stober, The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial diseae in nine diabetic population samples from the WHO multinational study, Diabetes Care 6:361 (1983).
D.B. Zilversmit, Atherogenesis: a postprandial phenomenon, Circulation 60:473 (1979).
B.H. Chung, J.P. Segrest, K. Smith, F.M. Griffin, and C.G. Brouillette, Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein, J. Clin. Invest. 83:1363 (1989).
J.S. Cohn, J.R. McNamara, S.D. Cohn, J.M. Ordovas, and E.J. Schaefer, Postprandial plasma lipoprotein changes in human subjects of different ages, J. Lipid Res. 29:469 (1988).
R.J. Havel, Early effects of fat ingestion on lipids and lipoproteins of serum in man, J. Clin. Invest. 36:848 (1957).
T.G. Redgrave, and L.A. Carlson, Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man, J. Lipid Res. 20:217 (1979).
G.R. Castro, and C.J. Fielding, Effects of postprandial lipemia on plasma cholesterol metabolism, J. Clin. Invest. 75:874 (1985).
I. Hjermann, K. Velve Byre, I. Holmf, P. Leren, Effect of diet and smoking intervention on the incidence of coronary heart disease, Lancet 2:1303 (1981).
Lipid Research Clinics Program, The Lipid Research Clinics Coronary Primary Prevention Trial Results: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251:365 (1984).
M.H. Frick, O. Elo, K. Haapa, O.P. Heinonen, P. Heinsalmi, P. Helo, J.K. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen, H. Maenpaa, M. Malkonen, M. Manttari, S. Norola, A. Pasternack, J. Pikkarainen, M. Romo, T. Sjoblom, and E.A. Nikkila, Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia, N. Engl. J. Med. 317:1237 (1987).
Committee of Principal Investigators, A co-operative trial in the primary prevention of ischaemic heart disease using Clofibrate, Br. Heart J. 40:1069 (1978).
L. Wilhelmsen, G. Berglund, D. Elmfeldt, G. Tibblin, H. Wedel, K. Pennert, A. Vedin, C. Wilhelmsson, and L. Werko, The multifactor primary prevention trial in Goteborg, Sweden, Eur. Heart J. 7:279 (1986).
D.H. Blankenhorn, S.A. Nessim, R. L. Johnson, M.E. Sanmarco, S.P. Azen, and L. Cashin-Hemphill, Beneficial effects of combined Colestipol-Niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA 257:3233 (1987).
B.G. Brown, E.L. Bolson, C.D. Pierce, R.B. Peterson, and H.T. Dodge, Regression of atherosclerosis in man: current data and their methodological limitations, in: “Regression of Atherosclerotic Lesions - Experimental Studies and Observations in Humans,” M. R. Malinow and V. H. Blaton, eds., Plenum Press, New York (1984).
D.H. Blankenhorn, R.L. Johnson, W.J. Mack, H.A. El Zein, and L. I. Vailas, The influence of diet on the appearance of new lesions in human coronary arteries, JAMA 263:1646 (1990).
C.J. Lavie, G.T. Gau, R.W. Squires, and B. A. Kottke, Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin. Proc. 63:605 (1988).
J.F.Brensike, R.I. Levy, S.F. Kelsey, E.R. Passamani, J.M. Richardson, I.K. Loh, N.J. Stone, R.F. Aldrich, J.W. Battaglini, D. J. Moriarty, M.R. Fisher, L. Friedman, W. Friedewald, K.M. Detre, and S.E. Epstein, Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study, Circulation 69:313 (1984).
A. Keys, F. Grande, and J.T. Anderson, Fiber and pectin in the diet and serum cholesterol concentration in man, Proc. Soc. Exp. Biol. Med. 106:555 (1961).
J.E. Garvin, D.T. Forman, W.R. Eiseman, and C.R. Phillips, Lowering of human serum cholesterol by an oral hydrophylic colloid, Proc. Soc. Exp. Biol. Med. 120:744 (1965).
J.W. Anderson, N. Zettwoch, T. Feldman, J. Tietyen-Clark, P. Oeltgen, and C.W. Bishop, Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men, Arch. Intern. Med. 148:292 (1988).
A.P. DeGroot, R. Luyken, and N.A. Pikaar, Cholesterol-lowering effect of rolled oats, Lancet 2:303 (1963).
D.J.A. Jenkins, D. Reynolds, B. Slavin, A.R. Leeds, A.L. Jenkins, and E.M. Jepson, Dietary fiber and blood lipids: treatment of hypercholesterolemia with guar crispbread, Am. J. Clin. Nutr. 33:575 (1980).
J.W. Anderson, and N. J. Gustafson, Alternative lipid-lowering diets, Practical Cardiology 14:84 (1988).
J.W. Anderson, L. Story, B. Sieling, W.-J.L. Chen, M.S. Petro, and J. Story, Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men, Am. J. Clin. Nutr. 40:1146 (1984).
J.W. Anderson, W.-J.L. Chen, and B. Sieling, Hypolipidemic effects of high-carbohydrate, high-fiber diets, Metabolism 29:551 (1980).
T. Gordon, A. Kagan, M. Garcia-Palmieri, W.B. Kannel, W.J. Zukel, J. Tillotson, P. Sorlie, and M. Hjortland, Diet and its relation to coronary heart disease and death in three populations, Circulation 63:500 (1981).
M.R. Garcia-Palmieri, P. Sorlie, J. Tillotson, R. Costas, E. Cordero, and M. Rodriguez, Relationship of dietary intake to subsequent coronary heart disease incidence: the Puerto Rico Heart Health Program, Am. J. Clin. Nutr. 33:1818 (1980).
D.L. McGee, D.M. Reed, K. Yano, A. Kagan, and J. Tillotson, Ten-year incidence of coronary heart disease in the Honolulu Heart Program, Am. J. Epidemiol. 119:667 (1984).
J.W. Anderson, Plant fiber and blood pressure, Ann. Intern. Med. 98:842 (1983).
J.W. Anderson and K. Ward, High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus, Am. J. Clin. Nutr. 32:2312 (1979).
H.C.R. Simpson, R.W. Simpson, S. Lousley, R.D. Carter, M. Geekie, T.D.R. Hockaday, and J.I. Mann, A high carbohydrate leguminous fibre diet improves all aspects of diabetic control, Lancet 1:1 (1981).
L. Story, J.W. Anderson, W.-J.L. Chen, D. Karounos, and B. Jefferson, Adherence to high-carbohydrate, high-fiber diets: long-term studies of non-obese diabetic men, J. Am. Diet. Assoc. 85:1105 (1985).
M. Krotkiewski, Effect of guar gum on body-weight, hunger ratings and metabolism in obese subjects, Br. J. Nutr. 52:97 (1984).
J.W. Anderson, and C.A. Bryant, Dietary fiber: diabetes and obesity, Am. J. Gastroenterol. 81:898 (1986).
D. Kromhout, E.B. Bosschieter, and C.D.L. Coulander, Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes, Lancet 2:518 (1982).
J.N. Morris, J.W. Marr, and D.G. Clayton, Diet and heart: a postscript, Br. Med. J. 2:1307 (1977).
L.H. Kushi, R.A. Lew, F.J. Stare, C.R. Ellison, M.E. Lozy, G. Bourke, L. Daly, I. Graham, N. Hickey, R. Mulcahy, and J. Kevaney, Diet and 20-year mortality from coronary heart Disease. The Ireland-Boston Diet-Heart Study, New Engl. J. Med. 312:811 (1985).
K.-T. Khaw and E. Barrett-Connor, Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study, Am. J. Epidemiol. 126:1093 (1987).
J. Hallfrisch, J. D. Tobin, D. C. Muller, and R. Andres, Fiber Intake, Age, and Other Coronary Risk Factors in Men of the Baltimore Longitudinal Study (1959–1975), J. Gerontology: Med. Sci. 43:M64 (1988).
D. Kromhout and C. de Lezenne Coulander, Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men: the Zutphen Study, Am. J. Epidemiol. 119:733 (1984).
The Expert Panel, Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults, Arch. Intern. Med. 148:36 (1988).
Study Group, European Atherosclerosis Society, Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society, Eur. Heart J. 8:77 (1987).
The Canadian Consensus Conference on the Prevention of Heart and Vascular Disease by Altering Serum Cholesterol and Lipoprotein Risk Factors, Canadian Consensus Conference on Cholesterol: A final report, Can. Med. Assoc. J. 139:1 (1988).
A Joint Statement of the Nutrition Committee and the Council on Arteriosclerosis, Recommendations for treatment of hyperlipidemia in adults, Circulation 69:1065A (1984).
L.-G. Ekelund, W.L. Haskell, J.L. Johnson, F.S. Whaley, M.H. Criqui, and D.S. Sheps, Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men, N.Engl. J. Med. 319:1379 (1988).
P.D. Wood, W.L. Haskell, H. Klein, S. Lewis, M.P. Stern, and J.W. Farquhar, The distribution of plasma lipoproteins in middle-aged male runners, Metabolism 25:1249 (1976).
J.W. Anderson, W.-J.L. Chen, and B. Sieling, Hypolipidemic effects of high-carbohydrate, high-fiber diets, Metabolism 29:551 (1980).
J.W. Anderson, and N.J. Gustafson, Dietary fiber and heart disease: current management concepts and recommendations, Top. Clin. Nutr. 3:21 (1988).
J.W. Anderson, “Be Heart Smart”, The HCF Nutrition Research Foundation, Inc., Lexington (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Anderson, J.W., Floore, T.L. (1990). Lipoproteins and Diet in the Pathogenesis of Atherosclerosis. In: Diana, J.N. (eds) Tobacco Smoking and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 273. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5829-9_24
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5829-9_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5831-2
Online ISBN: 978-1-4684-5829-9
eBook Packages: Springer Book Archive